**Core Concept**
Spasmodic dysmenorrhea is a type of primary dysmenorrhea characterized by painful menstrual cramps, often accompanied by nausea, vomiting, and diarrhea. The primary mechanism behind spasmodic dysmenorrhea involves the contraction of the uterine muscle, which is mediated by prostaglandins.

**Why the Correct Answer is Right**
Bromocriptine is a dopamine agonist that is primarily used in the treatment of prolactinomas and Parkinson's disease. It does not have a direct effect on prostaglandin synthesis or uterine smooth muscle contraction, making it an inappropriate choice for treating spasmodic dysmenorrhea. The other options, such as ibuprofen (a nonsteroidal anti-inflammatory drug), mefenamic acid (a nonsteroidal anti-inflammatory drug), and norethisterone and ethinyl estradiol (a combination oral contraceptive), work by reducing prostaglandin synthesis, inhibiting uterine contractions, or suppressing ovulation, respectively.

**Why Each Wrong Option is Incorrect**
**Option A:** Bromocriptine is not typically used for its anti-prostaglandin or anti-contraction properties, and its primary use in gynecology is not for the treatment of dysmenorrhea.
**Option B:** Ibuprofen is a correct treatment for spasmodic dysmenorrhea, as it inhibits prostaglandin synthesis and reduces uterine contractions.
**Option C:** Mefenamic acid is also a correct treatment for spasmodic dysmenorrhea, as it has anti-prostaglandin and anti-contraction properties.
**Option D:** Norethisterone and ethinyl estradiol, as a combination oral contraceptive, can help reduce menstrual cramps by suppressing ovulation and altering the endometrial environment.

**Clinical Pearl / High-Yield Fact**
When treating spasmodic dysmenorrhea, it's essential to consider the mechanism of action of the medication and choose a treatment that targets prostaglandin synthesis or uterine smooth muscle contraction.

**✓ Correct Answer: A. Bromocriptine**